市場調査レポート

商品コード

1701044

バイオマーカーの市場規模、シェア、成長分析：製品別、タイプ別、調査分野別、技術別、適応疾患別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Biomarkers Market Size, Share, and Growth Analysis, By Product, By Type, By Research Area, By Technology, By Disease Indication, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年04月02日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

バイオマーカー市場規模は2023年に582億米ドルとなり、予測期間（2025～2032年）のCAGRは13.5%で、2024年の660億6,000万米ドルから2032年には1,819億2,000万米ドルに成長する見通しです。

バイオマーカー市場は、主に慢性疾患の増加、テクノロジーの進歩、個別化医療への需要の高まりによって力強い成長を遂げています。世界の患者数の増加に伴い、バイオマーカーによる効果的な早期発見、モニタリング、診断の必要性が高まっています。プロテオミクス、ゲノム、メタボロミクス技術の革新は、新たなバイオマーカーの発見を促進し、市場拡大をさらに後押ししています。しかし、バイオマーカーの開発と検証に伴う高額なコストや、その利点に関する一般市民の認識が限定的であるなどの課題が、成長の妨げになる可能性があります。このような障害にもかかわらず、オーダーメイド医療や継続的な技術進歩という形で機会は豊富にあり、バイオマーカー市場は開発と投資の機が熟しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022～2024年）

主要企業プロファイル

Hoffmann-La Roche AG（Switzerland）
Thermo Fisher Scientific Inc.（United States）
Agilent Technologies, Inc.（United States）
QIAGEN N.V.（Netherlands）
Bio-Rad Laboratories, Inc.（United States）
Merck & Co., Inc.（United States）
PerkinElmer, Inc.（United States）
Illumina, Inc.（United States）
BD（Becton, Dickinson and Company）（United States）
Myriad Genetics, Inc.（United States）
Siemens Healthineers AG（Germany）
Danaher Corporation（United States）
Biomerieux SA（France）
Waters Corporation（United States）
Abbott Laboratories（United States）
Sysmex Corporation（Japan）
Bio-Techne Corporation（United States）
Charles River Laboratories International, Inc.（United States）
Eurofins Scientific SE（Luxembourg）

結論と提言

Product Code: SQMIG35A2509

Biomarkers Market size was valued at USD 58.2 billion in 2023 and is poised to grow from USD 66.06 billion in 2024 to USD 181.92 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).

The biomarkers market is experiencing robust growth, primarily fueled by the increasing prevalence of chronic diseases, advancements in technology, and a growing demand for personalized medicine. As global patient numbers rise, the need for effective early detection, monitoring, and diagnosis through biomarkers is intensifying. Innovations in proteomic, genomic, and metabolomics technologies are facilitating the discovery of new biomarkers, further propelling market expansion. However, challenges such as high costs associated with biomarker development and validation, as well as limited public awareness regarding their benefits, may hinder growth. Despite these obstacles, opportunities abound in the form of tailored medicine and continued technological advancements, making the biomarkers market ripe for development and investment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biomarkers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biomarkers Market Segments Analysis

Global Biomarkers Market is segmented by Product, Type, Research Area, Technology, Disease Indication, Application, End User and region. Based on Product, the market is segmented into Consumables, Services and Software. Based on Type, the market is segmented into Safety Biomarkers, Efficacy Biomarkers and Validation Biomarkers. Based on Research Area, the market is segmented into Genomics, Proteomics, Metabolomics and Other Research Areas. Based on Technology, the market is segmented into Immunoassays, NGS, PCR, Mass Spectrometry,Chromatographyand Other Technologies. Based on Disease Indication, the market is segmented into Cancer, Infectious Diseases, Immunological Disorders, Neurological Disorders, Cardiovascular Disorders and Other Disease Indications. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicine, Clinical Research and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biomarkers Market

The demand for biomarkers is rapidly increasing as healthcare shifts towards more personalized treatment approaches that consider the unique needs and genetic profiles of patients. This trend underscores the pivotal role of biomarkers in improving therapeutic outcomes. In recent years, the growth has been propelled by advanced research initiatives in biotechnology and molecular biology, which are facilitating the identification and application of novel biomarkers across various medical fields. As a result, there is a burgeoning interest in leveraging these biological indicators to tailor medical treatments, ultimately enhancing patient care and driving further innovation in the biomarkers market.

Restraints in the Biomarkers Market

The biomarkers market faces several significant challenges that could hinder its growth. Variability in biomarker testing methodologies and a lack of standardized practices across platforms can lead to inconsistent results, deterring widespread adoption. Additionally, the validation process for biomarkers associated with specific conditions and diseases often proves to be complex and time-consuming, further impeding progress. These hurdles not only slow the overall development of new biomarker technologies but also potentially restrict the market's expansion, as stakeholders may be hesitant to invest in uncertain outcomes or prolonged timelines for validation efforts.

Market Trends of the Biomarkers Market

The biomarker market is witnessing a significant trend towards the increased utilization of vitality biomarkers, which empower healthcare providers to assess patients' health proactively, even before symptoms manifest. This shift towards early intervention is crucial in averting the progression of various health conditions, thus enhancing patient outcomes. The integration of IoT devices and wearables into healthcare is further amplifying this trend, as these technologies enable continuous monitoring of vital health metrics in real-time. The resulting rich datasets not only facilitate personalized treatment plans but also bolster the quality of diagnostics, paving the way for innovative solutions in preventive medicine and chronic disease management.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Regulatory Analysis
Technology Analysis
Case Studies
Customer And Buying Criteria Analysis

Global Biomarkers Market Size by Product & Service & CAGR (2025-2032)

Market Overview
Consumables
- Assay Kits
- Reagents & Chemicals
- Columns & Filters
Services
Software

Global Biomarkers Market Size by Type & CAGR (2025-2032)

Market Overview
Safety Biomarkers
Efficacy Biomarkers
- Predictive Biomarkers
- Surrogate Biomarkers
- Pharmacodynamic Biomarkers
- Prognostic Biomarkers
Validation Biomarkers

Global Biomarkers Market Size by Research Area & CAGR (2025-2032)

Market Overview
Genomics
Proteomics
Metabolomics
Other Research Areas

Global Biomarkers Market Size by Technology & CAGR (2025-2032)

Market Overview
Immunoassays
- ELISA
- Protein Microarrays
- Western Blot
NGS
PCR
Mass Spectrometry
Chromatography
Other Technologies

Global Biomarkers Market Size by Disease Indication & CAGR (2025-2032)

Market Overview
Cancer
Infectious Diseases
Immunological Disorders
Neurological Disorders
Cardiovascular Disorders
Other Disease Indications

Global Biomarkers Market Size by Application & CAGR (2025-2032)

Market Overview
Clinical Diagnostics
Drug Discovery & Development
Personalized Medicine
Clinical Research
Other Applications

Global Biomarkers Market Size by End User & CAGR (2025-2032)

Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Academic & Research Institutes
Other End Users

Global Biomarkers Market Size & CAGR (2025-2032)

North America (Product & Service, Type, Research Area, Technology, Disease Indication, Application, End User)
- US
- Canada
Europe (Product & Service, Type, Research Area, Technology, Disease Indication, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Service, Type, Research Area, Technology, Disease Indication, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Service, Type, Research Area, Technology, Disease Indication, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Service, Type, Research Area, Technology, Disease Indication, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

バイオマーカーの市場規模、シェア、成長分析：製品別、タイプ別、調査分野別、技術別、適応疾患別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Biomarkers Market Size, Share, and Growth Analysis, By Product, By Type, By Research Area, By Technology, By Disease Indication, By Application, By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

バイオマーカー市場規模：製品・サービス別

バイオマーカー市場規模：タイプ別

バイオマーカー市場規模：調査分野別

バイオマーカー市場規模：技術別

バイオマーカー市場規模：適応疾患別

バイオマーカー市場規模：用途別

バイオマーカー市場規模：エンドユーザー別

バイオマーカー市場規模